Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.
Julie E BinesJarir At ThobariCahya Dewi SatriaAmanda HandleyEmma WattsDaniel CowleyHera NirwatiJames AcklandJane StandishFrances JusticeGabrielle ByarsKatherine J LeeGraeme L BarnesNovilia S BachtiarAjeng Viska IcanerviliaKaren BonifaceNada Bogdanovic-SakranDaniel PavlicRuth F BishopCarl D KirkwoodJim P ButteryYati SoenartoPublished in: The New England journal of medicine (2018)
RV3-BB was efficacious in preventing severe rotavirus gastroenteritis when administered according to a neonatal or an infant schedule in Indonesia. (Funded by the Bill and Melinda Gates Foundation and others; Australian New Zealand Clinical Trials Registry number, ACTRN12612001282875 .).